Patient Guide: A Study of Immune Checkpoint Inhibitor Combinations With Axitinib in Participants With Untreated Locally Advanced Unresectable or Metastatic Renal Cell Carcinoma

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 44 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05805501
Status: ACTIVE_NOT_RECRUITING
Condition: Renal Cell Carcinoma
Phase: PHASE2

Where You Can Participate

This study is available at 44 locations across the country.

Top locations include:
  • • Birmingham, Alabama
  • • Orange, California
  • • Washington D.C., District of Columbia
  • • And 41 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of Immune Checkpoint Inhibitor Combinations With Axitinib in Participants With Untreated Locally Advanced Unresectable or Metastatic Renal Cell Carcinoma - Join Clinical Trial NCTNCT05805501

How to Join This Clinical Trial - NCTNCT05805501

Learn how to participate in this PHASE2 trial studying an investigational therapy for Renal Cell Carcinoma. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Renal Cell Carcinoma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Renal Cell Carcinoma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT05805501 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 44 locations. Find a study site near you:

Clinical Research Site

Birmingham, Alabama 35294 - United States

Status: Contact for availability

Clinical Research Site

Orange, California 92868 - United States

Status: Contact for availability

Clinical Research Site

Washington D.C., District of Columbia 20016 - United States

Status: Contact for availability

Clinical Research Site

Atlanta, Georgia 30322 - United States

Status: Contact for availability

Clinical Research Site

Baltimore, Maryland 21287 - United States

Status: Contact for availability

Clinical Research Site

Nashville, Tennessee 37203 - United States

Status: Contact for availability

Clinical Research Site

Nashville, Tennessee 37232 - United States

Status: Contact for availability

Clinical Research Site

Dallas, Texas 75390-9179 - United States

Status: Contact for availability

Clinical Research Site

Birtinya, Queensland 4575 - Australia

Status: Contact for availability

Clinical Research Site

Beijing, 100034 - China

Status: Contact for availability

And 34 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Renal Cell Carcinoma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships